glp-1 drugs key developments 2025 2.0: Where the Next Wave of Value Will Be Created How Employers Can Manage GLP-1

Compounded GLP-1 medications are prepared by a pharmacist for each individual patient, sometimes at different doses or with different active forms of the drug than the FDA approved, brand-name medications

Organizations are balancing the ongoing demand from employees for GLP-1 coverage for weight loss by continuing to explore feasibility through cost-control mechanisms. Cost-Control Mechanisms Of those covering GLP-1 drugs, employers are using eligibility requirements (45%) and an annual maximum (32%) as cost-control mechanisms

Additional information Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

One of the more recent developments is the introduction of glucagon-like peptide-1 receptor agonists (GLP-1 RAs)

Mitochondrial dysfunction GLP-1 RAs enhance mitochondrial function through multiple interconnected mechanisms